Associated Papers
Germline mutations and somatic mosaicism in steatotic liver diseases and related liver carcinogenesis.
Trépo E et al.
Nature Reviews. Gastroenterology & Hepatology, 2026
Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis.
Cacciottolo TM et al.
Diabetes, 2025
40854221 (PubMed )
Supplement: db250209_supp.pdf
Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways.
Vujkovic M et al.
Medrxiv : the Preprint Server for Health Sciences, 2025
Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency.
Kohlmaier B et al.
International Journal of Obesity (2005), 2024
39277655 (PubMed )
Supplement: 41366_2024_1634_MOESM1_ESM.docx
Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update.
Sookoian S et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, 2024
The contribution of genetics and epigenetics to MAFLD susceptibility.
Moretti V et al.
Hepatology International, 2024
Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis.
Ghouse J et al.
Nature Genetics, 2024
Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK Biobank.
Nag A et al.
American Journal of Human Genetics, 2023
Multiomics study of nonalcoholic fatty liver disease.
Sveinbjornsson G et al.
Nature Genetics, 2022
Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis.
Carlsson B et al.
Alimentary Pharmacology & Therapeutics, 2020
Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond.
Krawczyk M et al.
Gastroenterology, 2020
Select a paper to view details